market cap 1.3 billion...buy AVXL for 3x current market cap.
if IBB continues to rise, so will AVXL..if IBB pulls back, AVXL may a bit too. But end of week it will be higher than 1.60. Getting ready for Nov 7th.
price will be above 2 before report....could jump to that next week, and then trend sideways for 2-3 weeks.
I am long, not short. But I am doing some level setting here. Still feel a 100% gain from today in 8-10 months is a great trade in AVXL. People here feel we are looking at 1000% gain in 1 year from now. That is not realistic.
pumping the stock is fine, but c'mon talk about 30-40 billion market cap in 2016 ?? without even phase 3 complete ??? who is on the pipe now.
yes 6-7 after 2b. That is correct. If 2b is going well they will definitely dilute in 2016, to raise cash for ph 3 preparation. So this is pump up market cap without price. Also don't forget warrants that will be sold when 2A bump happens to around $2.75.
As for epilepsy, parkinsons etc. those are just preclinical and phase 1. So not much value right now. And they don't have funds to proceed with moving these further. Their focus is going to be AD only.
Of course, if a big pharma comes in and funds them for eplipsy/pk, that is a different story.
Guys lets be realistic. This talk about $10-15 in 2015 is not going to happen.
I also expect dilution sometime 2016 for them to prepare for Phase 3 trials.
So my prediction -
Early Nov before conference - over $2.
After 2A results - $2.75 - $3.
Dilution in 2016.
Price in 2016 before 2B - $4.
Price in 2016 after 3B - $6-7.
At $7 we are already at $1Billion market cap.
is about $400M market cap at $3. Remember we still have to do Ph 2B.
$3 is still almost a double from here. If you want AXON type valuation, AVXL needs to show strong 2B too. And remember those warrants.
So I see market cap about 1Billion by late of 2016. A double after 2A. Stock price may not double due to warrants, but still big move.
This talk about $10-$15 in 2015 is not real.
no you don't understand it. Augment cost 15k....IVF cost the same. No one is doing both together. Only people who have failed multiple IVFs go for Augment.
And BTW, Augment is not approved in US.
the problem with ovas is that they are 2nd option after IVF. They are not worth 400m as 2nd option. Value will only go up if they become 1st option, and that can only happen with Overture, which is still some time away from commercialization.
hello ? can someone answer this instead of blatantly pumping.
why does yahoo show 132M market cap ? anyone ?? Is it accounting unsold warrants ?
Based on their burn rate, they will have about $4M in cash left..or less after liabilities. Not good for stock trading at 100M.
huge massive amount of warrants, very very low cash at hand, no news will be coming out till end of year (as per CEO). Don't be fooled anything will come in Sept.
Not looking good for next 1 month IMO.
market cap is at 211M already...not really a great bargin here given only 2a INITIAL results...not even 2a full results. Then comes 2b too.